Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B cell acute lymphoblastic leukemia

[1]  K. Coombes,et al.  Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia. , 2015, Cancer cell.

[2]  S. Hubbard,et al.  Targeting the Inactive Conformation of JAK2 in Hematological Malignancies. , 2015, Cancer cell.

[3]  C. Mullighan,et al.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications , 2015, Nature Reviews Clinical Oncology.

[4]  Yen-Yi Ho,et al.  The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in mice , 2014, Nucleic Acids Res..

[5]  Yi Zheng,et al.  Rational design of small molecule inhibitors targeting the Ras GEF, SOS1. , 2014, Chemistry & biology.

[6]  D. Patel,et al.  A molecular threading mechanism underlies Jumonji lysine demethylase KDM2A regulation of methylated H3K36 , 2014, Genes & development.

[7]  J. Zuber,et al.  Stage-specific control of early B cell development by the transcription factor Ikaros , 2014, Nature Immunology.

[8]  C. Eckert,et al.  Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. , 2013, Blood.

[9]  Jeffrey A. Magee,et al.  Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness , 2013, Nature.

[10]  C. Mullighan.  Genomic characterization of childhood acute lymphoblastic leukemia. , 2013, Seminars in hematology.

[11]  G. Stark,et al.  Role of lysine methylation of NF-κB in differential gene regulation , 2013, Proceedings of the National Academy of Sciences.

[12]  M. Loh,et al.  Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. , 2013, Journal of the National Cancer Institute.

[13]  A. Chakraborty,et al.  Activation of Extracellular Signal-Regulated Kinase but Not of p38 Mitogen-Activated Protein Kinase Pathways in Lymphocytes Requires Allosteric Activation of SOS , 2013, Molecular and Cellular Biology.

[14]  Kevin A. T. Silverstein,et al.  TAPDANCE: An automated tool to identify and annotate transposon insertion CISs and associations between CISs from next generation sequence data , 2012, BMC Bioinformatics.

[15]  Laura J. Norton,et al.  Impaired B Cell Development in the Absence of Krüppel-like Factor 3 , 2011, The Journal of Immunology.

[16]  T. Scheetz,et al.  Cell of origin strongly influences genetic selection in a mouse model of T-ALL. , 2011, Blood.

[17]  Michael N. Edmonson,et al.  Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2011, Blood.

[18]  T. Scheetz,et al.  Novel Molecular and Computational Methods Improve the Accuracy of Insertion Site Analysis in Sleeping Beauty-Induced Tumors , 2011, PloS one.

[19]  M. Farrar,et al.  Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia , 2011, The Journal of experimental medicine.

[20]  A. Eliopoulos,et al.  Tpl2 kinase signal transduction in inflammation and cancer. , 2011, Cancer letters.

[21]  Claire Schwab,et al.  Acute lymphoblastic leukaemia. , 2011, Methods in molecular biology.

[22]  A. Iwama,et al.  Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. , 2010, Cell stem cell.

[23]  G. Stark,et al.  Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65 , 2009, Proceedings of the National Academy of Sciences.

[24]  T. Scheetz,et al.  A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. , 2009, Cancer research.

[25]  M. Chance,et al.  Regulation of NF κB by NSD1/FBXL11-dependent reversible lysine methylation of p65 , 2009 .

[26]  Harinder Singh,et al.  Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development , 2009, Nature Immunology.

[27]  Y. Asmann,et al.  A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.

[28]  M. Farrar,et al.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. , 2009, Blood.

[29]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[30]  J. Downing,et al.  Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL. , 2008, Genes & development.

[31]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[32]  C. Sherr,et al.  The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. , 2008, Cold Spring Harbor symposia on quantitative biology.

[33]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[34]  M. Reth,et al.  Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.

[35]  D. Largaespada,et al.  Cancer Gene Discovery Using the Sleeping Beauty Transposon , 2005, Cell cycle.

[36]  Corey M. Carlson,et al.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse , 2005, Nature.

[37]  D. Largaespada,et al.  Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system , 2005, Nature.

[38]  M. Farrar,et al.  Distinct Effects of STAT5 Activation on CD4+ and CD8+ T Cell Homeostasis: Development of CD4+CD25+ Regulatory T Cells versus CD8+ Memory T Cells 1 , 2003, The Journal of Immunology.

[39]  A. Fornace,et al.  Loss of Oncogenic H-ras-Induced Cell Cycle Arrest and p38 Mitogen-Activated Protein Kinase Activation by Disruption of Gadd45a , 2003, Molecular and Cellular Biology.

[40]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[41]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[42]  Jiahuai Han,et al.  Mitogen‐activated protein kinase p38 defines the common senescence‐signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[43]  Shuang Huang,et al.  Sequential Activation of the MEK-Extracellular Signal-Regulated Kinase and MKK3/6-p38 Mitogen-Activated Protein Kinase Pathways Mediates Oncogenic ras-Induced Premature Senescence , 2002, Molecular and Cellular Biology.

[44]  R. Flavell,et al.  Activation of the p38 Mitogen-Activated Protein Kinase Pathway Arrests Cell Cycle Progression and Differentiation of Immature Thymocytes in Vivo , 2000, The Journal of experimental medicine.

[45]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[46]  J. Cyster,et al.  Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. , 1998, Immunity.